GBT
DGX icon

Grove Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Grove Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98.4K Hold
422
– – 0.01% 351
2026
Q2 		$89.4K Buy
422
+300
+246% +$58.9K 0.01% 360
2026
Q1 		$23.9K Hold
122
– – ﹤0.01% 517
2025
Q4 		$21.2K Hold
122
– – ﹤0.01% 538
2025
Q3 		$23.3K Hold
122
– – ﹤0.01% 519
2025
Q2 		$21.9K Buy
122
+14
+13% +$2.43K ﹤0.01% 522
2025
Q1 		$18.3K Buy
108
+93
+620% +$15.3K ﹤0.01% 532
2024
Q4 		$2.26K Buy
+15
New +$2.33K ﹤0.01% 676
2017
Q4 		– Sell
-60
Closed -$6K – 531
2017
Q3 		$6K Hold
60
– – ﹤0.01% 506
2017
Q2 		$7K Buy
+60
New +$6.34K ﹤0.01% 515

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Grove Bank & Trust's DGX Position: Q3 2026 in Review

Grove Bank & Trust held its Quest Diagnostics (DGX) position steady in Q3 2026 at 422 shares worth $98.4K. The position accounts for 0.01% of the portfolio, ranked #351.

Grove Bank & Trust first reported a position in DGX in Q2 2017 and has held it in 10 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Grove Bank & Trust held 422 shares of Quest Diagnostics worth $98.4K as of Q3 2026.
  • Grove Bank & Trust left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #351 holding.
  • Grove Bank & Trust first reported a position in Quest Diagnostics in Q2 2017 and has held it in 10 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.